[MONDAY MINUTE] Nestlé's $523M Secret Ozempic Strategy

Nestlé just dropped $523 million dollars to fully acquire the German complete nutrition brand Yfood. But don’t totally overlook this as just another simple brand acquisition. And that’s because it could become an important part of Nestle’s (mostly still disguised) global strategy to conquer the “Age of Ozempic” marketplace. Obviously, increasing household penetration of weight-loss drugs mean less food overall is being eaten, which has driven demand for hyper-concentrated, nutrient-dense meals, snacks, and liquids instead. But let’s see if Nestle begins to utilize Yfood as a gateway to drive GLP-1 patients into their new companion frozen food line…and eventually into personalized health platforms. Nevertheless, this isn’t a one-off, as Danone and Lactalis are buying up competitors too…further strengthening my long-held thesis that in the modern CPG business landscape, true power belongs to those not just feeding consumers (but fueling them).